270 related articles for article (PubMed ID: 25446678)
21. [On the Functional Cross-Talk between Brain 5-HT1A and 5-HT2A Receptors].
Naumenko VS; Bazovkina DV; Kondaurova EM
Zh Vyssh Nerv Deiat Im I P Pavlova; 2015; 65(2):240-7. PubMed ID: 26080602
[TBL] [Abstract][Full Text] [Related]
22. The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
Reckweg JT; Uthaug MV; Szabo A; Davis AK; Lancelotta R; Mason NL; Ramaekers JG
J Neurochem; 2022 Jul; 162(1):128-146. PubMed ID: 35149998
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
Ishima T; Futamura T; Ohgi Y; Yoshimi N; Kikuchi T; Hashimoto K
Eur Neuropsychopharmacol; 2015 Apr; 25(4):505-11. PubMed ID: 25687838
[TBL] [Abstract][Full Text] [Related]
24. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.
Riga MS; Soria G; Tudela R; Artigas F; Celada P
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1269-82. PubMed ID: 24650558
[TBL] [Abstract][Full Text] [Related]
25. Structural pharmacology and therapeutic potential of 5-methoxytryptamines.
Warren AL; Lankri D; Cunningham MJ; Serrano IC; Parise LF; Kruegel AC; Duggan P; Zilberg G; Capper MJ; Havel V; Russo SJ; Sames D; Wacker D
Nature; 2024 Jun; 630(8015):237-246. PubMed ID: 38720072
[TBL] [Abstract][Full Text] [Related]
26. Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome.
Shioda K; Nisijima K; Yoshino T; Kato S
Neurosci Lett; 2010 Oct; 482(3):216-9. PubMed ID: 20655983
[TBL] [Abstract][Full Text] [Related]
27. Role of 5-HT(1A)- and 5-HT(2A) receptors for the murine model of the serotonin syndrome.
Haberzettl R; Fink H; Bert B
J Pharmacol Toxicol Methods; 2014; 70(2):129-33. PubMed ID: 25087754
[TBL] [Abstract][Full Text] [Related]
28. 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.
Abiero A; Botanas CJ; Sayson LV; Custodio RJ; de la Peña JB; Kim M; Lee HJ; Seo JW; Ryu IS; Chang CM; Yang JS; Lee YS; Jang CG; Kim HJ; Cheong JH
Behav Brain Res; 2019 Feb; 359():828-835. PubMed ID: 30053461
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
30. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Darmani NA; Martin BR; Glennon RA
Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
[TBL] [Abstract][Full Text] [Related]
31. Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies.
Matsumoto K; Morishige R; Murakami Y; Tohda M; Takayama H; Sakakibara I; Watanabe H
Eur J Pharmacol; 2005 Jul; 517(3):191-9. PubMed ID: 15963493
[TBL] [Abstract][Full Text] [Related]
32. A narrative synthesis of research with 5-MeO-DMT.
Ermakova AO; Dunbar F; Rucker J; Johnson MW
J Psychopharmacol; 2022 Mar; 36(3):273-294. PubMed ID: 34666554
[TBL] [Abstract][Full Text] [Related]
33. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
Abdel-Fattah AF; Matsumoto K; Murakami Y; El-Hady KA; Mohamed MF; Watanabe H
Jpn J Pharmacol; 1996 Sep; 72(1):39-47. PubMed ID: 8902598
[TBL] [Abstract][Full Text] [Related]
34. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.
van den Buuse M; Ruimschotel E; Martin S; Risbrough VB; Halberstadt AL
Neuropharmacology; 2011; 61(1-2):209-16. PubMed ID: 21501627
[TBL] [Abstract][Full Text] [Related]
35. Hypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism.
Abdel-Fattah AF; Matsumoto K; Gammaz HA; Watanabe H
Pharmacol Biochem Behav; 1995 Oct; 52(2):421-6. PubMed ID: 8577810
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.
de Bortoli VC; Yamashita PS; Zangrossi H
J Psychopharmacol; 2013 Dec; 27(12):1116-23. PubMed ID: 23787365
[TBL] [Abstract][Full Text] [Related]
37. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
Commissaris RL; Davis M
Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
[TBL] [Abstract][Full Text] [Related]
38. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
39. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
[TBL] [Abstract][Full Text] [Related]
40. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
